FOR PAYERS
Smarter Care, Lower Cost
Our technologies target avoidable costs and treatment disruption by supporting patients, providers, and the systems around them.
Fewer side-effect costs
Better treatment adherence
Less pressure on clinics
FOR PAYERS
Smarter Care, Lower Cost
Our technologies target avoidable costs and treatment disruption by supporting patients, providers, and the systems around them.
Fewer side-effect costs
Better treatment adherence
Less pressure on clinics
FOR PAYERS
Smarter Care, Lower Cost
Our technologies target avoidable costs and treatment disruption by supporting patients, providers, and the systems around them.
Fewer side-effect costs
Better treatment adherence
Less pressure on clinics
Reduced Chair Time
Lotus helps shift oncology infusion treatments into the home, using technology to expand capacity and lower clinic costs.
51% of oncology clinics are overbooked
Shifting to a home infusion model can save payers up to 20%
Reduced Chair Time
Lotus helps shift oncology infusion treatments into the home, using technology to expand capacity and lower clinic costs.
51% of oncology clinics are overbooked
Shifting to a home infusion model can save payers up to 20%
Reduce Chair Time
Lotus helps bring oncology infusion treatments into the home, using technology to expand capacity and lower clinic costs.
51% of US oncology clinics are already overbooked
Home infusion saves payers over 20%
Improved Adherence
Lilac supports better symptom management, leading to fewer delays and avoidable dose reductions.
68% of patients get life-changing neuropathy due to their treatment
Improved Adherence
Lilac supports better symptom management, leading to fewer delays and avoidable dose reductions.
68% of patients get life-changing neuropathy due to their treatment
Improved Adherence
Lilac supports better symptom management, leading to fewer treatment delays and avoidable dose reductions
68% of cancer patients develop life-changing neuropathy due to treatment
Higher Patient Satisfaction
Lily helps members maintain a sense of identity during treatment, improving emotional resilience and overall care perception.
47% of breast cancer patients find hair loss highly traumatic
Higher Patient Satisfaction
Lily helps members maintain a sense of identity during treatment, improving emotional resilience and overall care perception.
47% of breast cancer patients find hair loss highly traumatic
Higher Patient Satisfaction
Lily helps members maintain a sense of identity during treatment, improving emotional resilience and overall care perception.
47% of patients found hair loss the most traumatic part of breast cancer
Built for impact where it matters most.
We design our solutions to ease pressure on providers, reduce unnecessary costs, and help members' treatment stay on track with fewer disruptions. By addressing the overlooked drivers of complexity - like side effects, time in clinic, and emotional fatigue - we create room for better outcomes and better experiences.
Built for impact where it matters most.
We design our solutions to ease pressure on providers, reduce unnecessary costs, and help members' treatment stay on track with fewer disruptions. By addressing the overlooked drivers of complexity - like side effects, time in clinic, and emotional fatigue - we create room for better outcomes and better experiences.
Built for impact where it matters most.
Treating cancer is a $1T annual bill, which continues to rise. Our products are designed to ease pressure on providers, reduce unnecessary costs, and help members stay on treatment with fewer disruptions. By addressing the overlooked drivers of complexity - like side effects, time in clinic, and emotional fatigue - we create room for better outcomes and better experiences.
“
Hair retention is important for me, because cancer coupled with hair loss is too much stress for me to deal with.
”
Lily Clinical Trial Participant
“
Hair retention is important for me, because cancer coupled with hair loss is too much stress for me to deal with.
”
Lily Clinical Trial Participant
“
Hair retention is important for me, because cancer coupled with hair loss is too much stress for me to deal with.
”
Lily Clinical Trial Participant
Targeted Solutions, Measurable Impacts.
We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.
Lotus
Enables safe, at-home cancer treatment — reducing clinic demand and improving patient access.
Lilac
Helps prevent nerve damage that often leads to dose reductions, treatment dropouts, and downstream costs.
Lily
Reduces hair loss, improving patient wellbeing and satisfaction with care.
Targeted Solutions, Measurable Impacts.
We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.
Lotus
Enables safe, at-home cancer treatment — reducing clinic demand and improving patient access.
Lilac
Helps prevent nerve damage that often leads to dose reductions, treatment dropouts, and downstream costs.
Lily
Reduces hair loss, improving patient wellbeing and satisfaction with care.
Targeted Solutions, Measurable Impacts.
We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.
Lotus
Enables safe, at-home cancer treatment — reducing clinic demand and improving patient access.
Lilac
Helps prevent nerve damage that often leads to dose reductions, treatment dropouts, and downstream costs.
Lily
Reduces hair loss, improving patient wellbeing and satisfaction with care.
How it fits in
Our technologies are already in use across clinical settings and pilot programs. Each solution is designed to integrate with existing care pathways and teams - making adoption simple, scalable, and system-ready from day one.
How it fits in
Our technologies are already in use across clinical settings and pilot programs. Each solution is designed to integrate with existing care pathways and teams - making adoption simple, scalable, and system-ready from day one.
How it fits in
Our technologies are already in use across clinical settings and pilot programs. Each solution is designed to integrate with existing care pathways and teams - making adoption simple, scalable, and system-ready from day one.
“
I'm proud to keep my hair, I'd recommend that everyone wears Lily
”
Lily Clinical Trial Participant
“
I'm proud to keep my hair, I'd recommend that everyone wears Lily
”
Lily Clinical Trial Participant
“
I'm proud to keep my hair, I'd recommend that everyone wears Lily
”
Lily Clinical Trial Participant
Enabling value-based cancer care at scale
We work directly with payers and provider networks to design pilots, deploy solutions, and measure outcomes. Our approach is flexible, compliant, and built to integrate into existing care pathways.
By reducing the cost of care and improving the member experience, we help partners shift from reactive treatment to proactive support.
Enabling value-based cancer care at scale
We work directly with payers and provider networks to design pilots, deploy solutions, and measure outcomes. Our approach is flexible, compliant, and built to integrate into existing care pathways.
By reducing the cost of care and improving the member experience, we help partners shift from reactive treatment to proactive support.
Enabling value-based cancer care at scale
We work directly with payers and provider networks to design pilots, deploy solutions, and measure outcomes. Our approach is flexible, compliant, and built to integrate into existing care pathways.
By reducing the cost of care and improving the member experience, we help partners shift from reactive treatment to proactive support.
Let’s explore the
impact, together
We’re partnering with organizations to bring more efficient, outcome-focused cancer care into the real world.
If you’re interested in piloting, modelling cost impact, or discussing integration then we’d love to hear from you.
Let’s explore the impact, together
We’re partnering with organizations to bring more efficient, outcome-focused cancer care into the real world.
If you’re interested in piloting, modelling cost impact, or discussing integration then we’d love to hear from you.
Let’s explore the impact, together
We’re partnering with organizations to bring more efficient, outcome-focused cancer care into the real world.
If you’re interested in piloting, modelling cost impact, or discussing integration then we’d love to hear from you.
We build technologies that help oncologists make cancer care better for patients.
People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
FUNDED BY
On Trial At
Featured In
We build technologies that help oncologists make cancer care better for patients.
People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
FUNDED BY
On Trial At
Featured In
We build technologies that help oncologists make cancer care better for patients.
People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
FUNDED BY
On Trial At
Featured In